Article

Hyperkalemia Secondary to Acute Renal Failure

A 35-year-old man presents to the emergency department complaining of syncope. He denies any preceding chest pain, palpitations or trouble breathing, and states he did not injure himself other than a bump on his forehead.

A 35-year-old man presents to the emergency department complaining of syncope. He denies any preceding chest pain, palpitations or trouble breathing, and states he did not injure himself other than a bump on his forehead. On arrival he says he has a mild headache but has not vomited and the headache is improving. He mentions that for the past few days he has had a “pins-and-needles” sensation in both hands and has experienced generalized weakness, but has been able to function. He is otherwise healthy and does not routinely see a doctor.

Physical examination is unremarkable except for a blood pressure measurement of 189/122 mm Hg and a contusion just above his eyebrow. His lungs are clear and he has no cardiac murmur. He also has a normal neurologic exam including short-term memory so a CT of the head is not ordered.

Blood is sent for routine laboratory work up and an ECG is done; the tracing is shown in the Figure.

Figure. ECG tracing post syncope

 

 

 

 

 

 

 

 

What ECG findings should you look for in a tracing for a patient who has fainted?

What does this ECG suggest?

Answers

In general, in a patient with syncope, the ECG should be checked for abnormal intervals rather than for signs of ischemia. A short PR interval or a long QT interval could be a hint that there has been a recent dysrhythmia. Other conditions to look for that are beyond the scope of this article would be Brugada syndrome or an epsilon wave.

Although this patient’s ECG shows somewhat peaked T waves that could be consistent with benign early repolarization, the differential diagnosis of pronounced or peaked T-waves also includes electrolyte abnormalities, especially hyperkalemia. The patient’s potassium level came back at 8.4 mEq/L without hemolysis. He was in acute renal failure, likely the result of long-standing undiagnosed hypertension.

Discussion

Hyperkalemia is often asymptomatic, but as the potassium level rises it may produce, fatigue, generalized muscle weakness, and paresthesias. The most feared complications of hyperkalemia involve cardiac electrical and rhythm disturbances, usually starting with peaked T waves and prolongation of the PR interval but progressing to bradycardia, a variety of types of heart blocks, and eventually asystole (see Table 1 for additional information).

There are a number of causes of and contributors to hyperkalemia. Usually there is renal insufficiency present of some degree, but a number of other medical conditions and multiple common medications, eg, sulfa antibiotic and ACE inhibitors to name a few, often contribute to this potentially life threatening electrolyte abnormality (see Table 2 for additional details).

Treatment of hyperkalemia can be categorized by mechanism of action. Intravenous calcium acts rapidly and helps to stabilize the cardiac membrane. Insulin + dextrose, albuterol, and sodium bicarbonate all act fairly quickly to shift potassium into cells, temporarily lowering serum levels. Furosemide (Lasix), sodium polystyrene (Kayexylate), and hemodialysis all remove potassium permanently from the body but may take hours to take effect (see chart below for details). Depending on the potassium level and ECG changes, one, more, or all of these medications may be used.

Table 1.

HYPERKALEMIA

from Quick Essentials Emergency Medicine 1-minute Consult pocketbook

Clinical:
Fatigue, muscle weakness, hand paresthesias, palpitations. Often asymptomatic.
Causes:
“BAD STAR”: Beta blockers, ACE inhibitors, Aldactone, Digoxin,
 ECG:
Peaked T, early repol > long PR, bradycardia > right bundle branch block, wide QRS, axis changes > sinus pause, junctional rhythm, left bundle branch block, asystole

Table 2.

Treatment

Ca-gluconate*
Bicarb
Albuterol
Insulin*/D50
Kayexlyate

Lasix

Indication
 

K>7, incr ­QRS, decr Ca*

acidotic
K>6
K>6
K>5.5
K>5.5

cardiac protection

shift
shift
shift
elimination
elimination

3 amps over 3 min

1-3 amps
10-20 mg
5U/D50
15-50 g
40-80 mg

1-3 min

5-10 min
15 min
30 min
1-2 h
w/diuresis

avoid in digoxin OD

lowers ca
tachycardia
hypoglycemia
CHF
lowers Mg

30-60 min

1-2 h
1h
4-6 h
4-6 h
during diuresis
  • Calcium: some use if K>6.5 or in rhabdo or tumor lysis (rapid K incr­). Insulin: use ≤5units if renal or liver disease.

Click on Image for Details

Table 2.

Related Videos
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.